会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Deflection yoke
    • 偏转轭
    • US6124773A
    • 2000-09-26
    • US009885
    • 1998-01-21
    • Yusuke OkawaHiroshi KimuraTakasuke KogaNaoki Hatakeyama
    • Yusuke OkawaHiroshi KimuraTakasuke KogaNaoki Hatakeyama
    • H01J29/76H01F5/04H01J29/82H01J29/98H01F7/00
    • H01F5/04H01J29/826H01J29/98H01J2229/92
    • A deflection yoke includes a coil, a base board, and a terminal. The terminal is mounted on the base board. The terminal extends from the base board. The terminal has a first portion and a second portion. The first portion of the terminal extends from the base board and has a substantially circular cross-section. The second portion of the terminal extends from the first portion thereof and has a cross-section with a corner. A lead extending from the coil is wound on the first and second portions of the terminal as a winding on the terminal. The winding has a first portion and a second portion. The first portion of the winding extends around the first portion of the terminal. The second portion of the winding extends around the second portion of the terminal. At least part of of the second portion of the winding is soldered to the second portion of the terminal while at least part of the first portion of the winding is non-soldered.
    • 偏转线圈包括线圈,基板和端子。 端子安装在基板上。 终端从基板延伸。 端子具有第一部分和第二部分。 端子的第一部分从基板延伸并且具有大致圆形的横截面。 端子的第二部分从其第一部分延伸并且具有与拐角的横截面。 从线圈延伸的引线作为端子上的绕组缠绕在端子的第一和第二部分上。 绕组具有第一部分和第二部分。 绕组的第一部分围绕端子的第一部分延伸。 绕组的第二部分围绕端子的第二部分延伸。 绕组的第二部分的至少一部分被焊接到端子的第二部分,而绕组的第一部分的至少一部分未被焊接。
    • 6. 发明授权
    • Emulsified composition for dilution and cancer vaccine composition
    • 用于稀释和癌症疫苗组合物的乳化组合物
    • US08178102B2
    • 2012-05-15
    • US11814270
    • 2006-01-19
    • Koichi SaitoYusuke Okawa
    • Koichi SaitoYusuke Okawa
    • A61K39/39B01F3/08
    • C07K7/08A61K9/0019A61K9/107A61K39/0011A61K47/14A61K2039/55566C07K7/06
    • Provided is an emulsified composition for diluting a cancer antigen peptide or a dimer thereof. Also provided is a novel cancer vaccine composition or specific CTL inducer that efficiently induces CTL irrespective of the type of cancer antigen peptide when mixing the emulsified composition for dilution and a water phase comprising a cancer antigen peptide or a dimer thereof.The present invention relates to an emulsified composition for diluting a cancer antigen peptide or a dimer thereof, comprising a particular ester, a particular surfactant, a particular emulsifier, and a water phase. The present invention also relates to a cancer vaccine composition or specific CTL inducer obtained by freshly diluting and mixing a water phase comprising a cancer antigen peptide or a dimer thereof with the emulsified composition for dilution.
    • 提供了用于稀释癌抗原肽或其二聚体的乳化组合物。 还提供了当混合用于稀释的乳化组合物和包含癌抗原肽或其二聚体的水相时,与癌抗原肽类型无关地有效诱导CTL的新型癌症疫苗组合物或特异性CTL诱导剂。 本发明涉及用于稀释癌抗原肽或其二聚体的乳化组合物,其包含特定的酯,特定的表面活性剂,特定的乳化剂和水相。 本发明还涉及通过将包含癌抗原肽或其二聚体的水相与用于稀释的乳化组合物新鲜稀释和混合而获得的癌症疫苗组合物或特异性CTL诱导剂。
    • 8. 发明申请
    • EMULSIFIED COMPOSITION FOR DILUTION AND CANCER VACCINE COMPOSITION
    • 用于稀释和癌症疫苗组合物的乳化组合物
    • US20090136572A1
    • 2009-05-28
    • US11814270
    • 2006-01-19
    • Koichi SaitoYusuke Okawa
    • Koichi SaitoYusuke Okawa
    • A61K9/14A61K39/00A61K47/00
    • C07K7/08A61K9/0019A61K9/107A61K39/0011A61K47/14A61K2039/55566C07K7/06
    • Provided is an emulsified composition for diluting a cancer antigen peptide or a dimer thereof. Also provided is a novel cancer vaccine composition or specific CTL inducer that efficiently induces CTL irrespective of the type of cancer antigen peptide when mixing the emulsified composition for dilution and a water phase comprising a cancer antigen peptide or a dimer thereof.The present invention relates to an emulsified composition for diluting a cancer antigen peptide or a dimer thereof, comprising a particular ester, a particular surfactant, a particular emulsifier, and a water phase. The present invention also relates to a cancer vaccine composition or specific CTL inducer obtained by freshly diluting and mixing a water phase comprising a cancer antigen peptide or a dimer thereof with the emulsified composition for dilution.
    • 提供了用于稀释癌抗原肽或其二聚体的乳化组合物。 还提供了当混合用于稀释的乳化组合物和包含癌抗原肽或其二聚体的水相时,与癌抗原肽类型无关地有效诱导CTL的新型癌症疫苗组合物或特异性CTL诱导剂。 本发明涉及用于稀释癌抗原肽或其二聚体的乳化组合物,其包含特定的酯,特定的表面活性剂,特定的乳化剂和水相。 本发明还涉及通过将包含癌抗原肽或其二聚体的水相与用于稀释的乳化组合物新鲜稀释和混合而获得的癌症疫苗组合物或特异性CTL诱导剂。